Genasys Inc. Announces $9.7 Million Follow-On Program of Record Order from U.S. Army
Genasys Inc. (NASDAQ: GNSS), the global leader in critical
communications systems and solutions, today announced a follow-on
$9.7 million order from the U.S. Army (Army). This is the third
LRAD® 450XL order received by the Company in fiscal 2021 under the
Army's Acoustic Hailing Device (AHD) program of record.
“Military Police, Transportation Security and
PSYOPS units in the Army’s Active, Reserve and Guard will deploy
these systems across the full spectrum of conflict, including
training, disaster response, and military operations,” said Richard
S. Danforth, Chief Executive Officer of Genasys Inc. “As the Army’s
AHD of choice, the LRAD 450XL provides critical long-range
communication and scalable escalation of force capabilities that
increase the decision time and distance for military personnel to
differentiate between security threats and non-combatants, resolve
uncertain situations, and save lives.”
Low profile, lightweight and designed to be
mounted on tripods, vehicles, small vessels and Common Remotely
Operated Weapon Stations (CROWS), the LRAD 450XL incorporates
LRAD’s patented technology to generate the audio output of a unit
almost twice its size and weight with the same high level of
clarity and intelligibility consistent with the LRAD product
The LRAD 450XL is the AHD of Choice for U.S. and
international defense, homeland security, and law enforcement
About Genasys Inc.
Genasys™ is a global provider of critical communications
systems and solutions that help keep people safe. Genasys
systems are in service in more than 100 countries in a range of
diverse applications, including public safety, emergency warning,
mass notification, critical event management, defense, law
enforcement, homeland security, and many more. For more
information, visit genasys.com.
Except for historical information contained
herein, the matters discussed are forward-looking statements within
the meaning of Section 21E of the Securities Exchange Act of 1934.
You should not place undue reliance on these statements. We base
these statements on particular assumptions that we have made in
light of our industry experience, the stage of product and market
development as well as our perception of historical trends, current
market conditions, current economic data, expected future
developments and other factors that we believe are appropriate
under the circumstances. These statements involve risks and
uncertainties that could cause actual results to differ materially
from those suggested in the forward-looking statements. These
forward-looking statements are subject to a number of risks and
uncertainties, including without limitation the business impact of
health crises or outbreaks of disease, such as epidemics or
pandemics and how they may affect our supply chain, and other risks
and uncertainties, many of which involve factors or circumstances
that are beyond the Company's control. Risks and uncertainties are
identified and discussed in our filings with the Securities and
Exchange Commission. These forward-looking statements are based on
information and management’s expectations as of the date hereof.
Future results may differ materially from our current expectations.
For more information regarding other potential risks and
uncertainties, see the “Risk Factors” section of the Company’s Form
10-K for the fiscal year ended September 30, 2020. Genasys Inc.
disclaims any intent or obligation to update those forward-looking
statements, except as otherwise specifically stated.
Investor Relations Contacts
Jim Fanucchi and Satya Chillara
Darrow Associates, Inc.
Historical Stock Chart
From Sep 2021 to Oct 2021
Historical Stock Chart
From Oct 2020 to Oct 2021